Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin type A is a safe and effective treatment for male pattern baldness.

Familial factors affect hair loss types in Koreans, with M type in men, L type in women, and paternal factors influencing male hair loss more.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Laser treatment for hair loss works equally well on different skin types, but more research is needed for very dark skin.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Higher sebum levels are linked to more severe male baldness.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

Best hair growth results from combining finasteride and minoxidil.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Rothmund-Thomson syndrome type 2 can cause chronic, poorly healing wounds.

Finasteride and minoxidil are the main effective treatments for hair loss from androgenetic alopecia.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Acne severity is not related to the type or severity of androgenetic alopecia.

Hair loss in men is common, treatable, but not curable.

Genes and hormones cause hair loss, with four genes contributing equally.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

58% of men aged 30-50 have hair loss, with severity increasing with age.

Hair loss from genetics and hormones can be treated with drugs or surgery.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Early hair loss may indicate risk of insulin resistance.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Topical minoxidil is effective and safe for hair regrowth in Middle Eastern men with early baldness, with better results in younger patients and certain types of baldness.